Mineralocorticoid receptor antagonist for renal protection.
about
Finerenone : third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease.Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.Parathyroid hormone, vitamin D levels and urine albumin excretion in older persons: the 2011 Korea National Health and Nutrition Examination Survey (KNHANES).A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients.Elevated FGF23 Levels in Mice Lacking the Thiazide-Sensitive NaCl cotransporter (NCC).
P2860
Mineralocorticoid receptor antagonist for renal protection.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mineralocorticoid receptor antagonist for renal protection.
@en
Mineralocorticoid receptor antagonist for renal protection.
@nl
type
label
Mineralocorticoid receptor antagonist for renal protection.
@en
Mineralocorticoid receptor antagonist for renal protection.
@nl
prefLabel
Mineralocorticoid receptor antagonist for renal protection.
@en
Mineralocorticoid receptor antagonist for renal protection.
@nl
P2860
P1433
P1476
Mineralocorticoid receptor antagonist for renal protection.
@en
P2093
Terry King-Wing Ma
P2860
P304
P356
10.3109/0886022X.2012.672156
P577
2012-04-02T00:00:00Z